Many arise spontaneously in germ cells; may explain why autism risk higher among children of older fathers
New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to discover biomarkers that can be used to facilitate the development of safe, effective and personalized treatments of autism spectrum disorders (ASD).
This month’s issue of the Archives of General Psychiatry features an editorial commentary by Autism Speaks Chief Science Officer Geraldine Dawson, Ph.D. In it, Dr.
A large clinical trial will test the safety and effectiveness of oxytocin nasal spray to improve sociability and communication in children and teens with autism. The federally funded clinical trial follows the promising results of a pilot study funded by Autism Speaks.
The U.S. Interagency Autism Coordinating Committee (IACC) and the Office of Autism Research Coordination (OARC) have released their inaugural report on autism publications across the last 30 years.
New York, N.Y. (June 21, 2012) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced the award of new research grants totaling nearly $2.9 million in funding to support autism research.